Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting proteins involved in cancer pathways such as JAK and FLT3. Its structure enables selective binding to ATP sites in kinases, making it valuable in developing drugs for hematological malignancies and inflammatory diseases. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable hydrogen bonding and π-stacking properties.